Nutraceutical Regulations and Registration in European Union (EU-EMA)
At a CAGR of 4.91% over the projected period (2023-2028), the Europe Nutraceutical Market is anticipated to increase from USD […]
At a CAGR of 4.91% over the projected period (2023-2028), the Europe Nutraceutical Market is anticipated to increase from USD […]
The European pharmaceutical market is expected to reach USD 432.12 billion by 2028, growing at a CAGR of 5.4%. Cancer
In 2022, the Europe biosimilar market had a value of almost USD 4601.56 million. In addition, it is anticipated that
The new EU Clinical Trial Regulation (CTR) 536/2014, which came into effect on January 31, 2022, represents a significant overhaul
The European Union Medical Device Regulation (EU MDR) represents a significant overhaul of the regulatory framework for medical devices in
The medical devices market in Europe has exhibited impressive value, surpassing USD 140.07 billion in 2022. Experts predict that this
In the intricate landscape of pharmaceutical regulation, ensuring the safety and efficacy of medicinal products is paramount. At the heart